Kardigan
Kardigan develops personalized medicines using AI and data to target and treat the root causes of cardiovascular diseases.
About Kardigan
Kardigan is a biopharmaceutical company developing a pipeline of personalized medicines to treat and potentially cure cardiovascular diseases. The company utilizes a proprietary Cardiac Intelligence R&D platform to confirm markers for safety, efficacy, and patient selection before human trials. Kardigan integrates AI-based tools into its clinical trials to optimize study design and increase confidence in results.
Company Facts
- Headquarters
- South San Francisco
- Operating Status
- active
- Company Type
- for_profit
- IPO Status
- private
- Employees
- c_00051_00100
- Funding Stage
- early_stage_venture
- Total Funding
- $554,000,000
- Last Funding Type
- series_b
- Last Funding Date
- 2025-10-14
- Website
- kardigan.bio
Industries & Categories
Artificial Intelligence (AI), Biopharma, Health Care, Medical
Social Links
Canonical: https://fsome.com/organization/kardigan-118540 · For the full interactive profile (funding rounds, investors, team, portfolio, charts), please enable JavaScript.